Patrick J.  Zenner net worth and biography

Patrick Zenner Biography and Net Worth

Mr. Zenner was elected Chairman of the Board effective July 1, 2015. He retired from Hoffmann-La Roche Inc., North America—the prescription drug unit of the Roche Group, a leading research-based healthcare enterprise—in 2001, where he served as President and Chief Executive Officer from 1993 to 2001. He served as Interim Chief Executive Officer of CuraGen Corporation from May 2005 through March 2006. Since then, Mr. Zenner was a director and Chairman of the Board of Exact Sciences Corporation until July 2010 and served as its Interim CEO from July 2007 to March 2008. Currently, Mr. Zenner serves as a director of Selecta Biosciences and is also a member of the Board of Trustees of Creighton University, Biosciences, Inc. and the Board of Trustees of Fairleigh Dickinson University.

What is Patrick J. Zenner's net worth?

The estimated net worth of Patrick J. Zenner is at least $20.73 million as of July 31st, 2020. Mr. Zenner owns 66,475 shares of West Pharmaceutical Services stock worth more than $20,728,899 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Zenner may own. Learn More about Patrick J. Zenner's net worth.

How do I contact Patrick J. Zenner?

The corporate mailing address for Mr. Zenner and other West Pharmaceutical Services executives is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. West Pharmaceutical Services can also be reached via phone at (610) 594-2900 and via email at [email protected]. Learn More on Patrick J. Zenner's contact information.

Has Patrick J. Zenner been buying or selling shares of West Pharmaceutical Services?

Patrick J. Zenner has not been actively trading shares of West Pharmaceutical Services during the last ninety days. Most recently, on Saturday, October 17th, Patrick J. Zenner bought 335 shares of West Pharmaceutical Services stock. The stock was acquired at an average cost of $93.94 per share, with a total value of $31,469.90. Following the completion of the transaction, the director now directly owns 66,475 shares of the company's stock, valued at $6,244,661.50. Learn More on Patrick J. Zenner's trading history.

Who are West Pharmaceutical Services' active insiders?

West Pharmaceutical Services' insider roster includes Silji Abraham (Insider), Bernard Birkett (SVP), Annette Favorite (VP), Eric Green (CEO), Thomas Hofmann (Director), Quintin Lai (VP), George Miller (VP), Cindy Reiss-Clark (Insider), Chad Winters (CAO), and Patrick Zenner (Director). Learn More on West Pharmaceutical Services' active insiders.

Are insiders buying or selling shares of West Pharmaceutical Services?

In the last twelve months, insiders at the medical instruments supplier sold shares 10 times. They sold a total of 145,140 shares worth more than $52,554,297.12. The most recent insider tranaction occured on October, 29th when VP Charles Witherspoon sold 703 shares worth more than $218,211.20. Insiders at West Pharmaceutical Services own 0.5% of the company. Learn More about insider trades at West Pharmaceutical Services.

Information on this page was last updated on 10/29/2024.

Patrick J. Zenner Insider Trading History at West Pharmaceutical Services

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/17/2020Buy335$93.94$31,469.9066,475View SEC Filing Icon  
7/31/2020Buy57$110.55$6,301.3566,475View SEC Filing Icon  
7/25/2020Sell47$132.22$6,214.3466,475View SEC Filing Icon  
7/18/2020Sell20$121.83$2,436.6066,475View SEC Filing Icon  
3/21/2020Sell33$106.49$3,514.1766,475View SEC Filing Icon  
3/19/2020Sell11$106.02$1,166.2266,475View SEC Filing Icon  
2/28/2020Buy54$105.14$5,677.5666,475View SEC Filing Icon  
5/15/2018Buy275$88.89$24,444.7556,540View SEC Filing Icon  
12/8/2016Buy332$84.53$28,063.96View SEC Filing Icon  
2/23/2015Sell12,800$53.69$687,232.00View SEC Filing Icon  
2/26/2014Sell12,800$46.12$590,336.00View SEC Filing Icon  
See Full Table

Patrick J. Zenner Buying and Selling Activity at West Pharmaceutical Services

This chart shows Patrick J Zenner's buying and selling at West Pharmaceutical Services by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

West Pharmaceutical Services Company Overview

West Pharmaceutical Services logo
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Read More

Today's Range

Now: $311.83
Low: $308.45
High: $313.26

50 Day Range

MA: $306.23
Low: $286.40
High: $344.12

2 Week Range

Now: $311.83
Low: $265.00
High: $413.70

Volume

26,807 shs

Average Volume

572,037 shs

Market Capitalization

$22.58 billion

P/E Ratio

46.27

Dividend Yield

0.28%

Beta

1